Results 11 to 20 of about 5,549,552 (344)

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

open access: yesmedRxiv, 2021
Background: The efficacy of interleukin-6 receptor antagonists in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear. Methods: We evaluated tocilizumab and sarilumab in an ongoing international, multifactorial, adaptive platform ...
A. Gordon   +61 more
semanticscholar   +1 more source

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

open access: yesNew England Journal of Medicine, 2021
Background Thrombosis and inflammation may contribute to morbidity and mortality among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation would improve outcomes in critically ill patients with Covid ...
E. Goligher   +167 more
semanticscholar   +1 more source

2022 Society of Critical Care Medicine Clinical Practice Guidelines on Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility

open access: yesPediatric Critical Care Medicine, 2022
Supplemental Digital Content is available in the text. RATIONALE: A guideline that both evaluates current practice and provides recommendations to address sedation, pain, and delirium management with regard for neuromuscular blockade and withdrawal is ...
Heidi A. B. Smith   +28 more
semanticscholar   +1 more source

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

open access: yesmedRxiv, 2020
Background: Nearly 30,000 patients with coronavirus disease-2019 (COVID-19) have been hospitalized in New York City as of April 14th, 2020. Data on the epidemiology, clinical course, and outcomes of critically ill patients with COVID-19 in this setting ...
M. Cummings   +14 more
semanticscholar   +2 more sources

Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

open access: yesCritical Care Medicine, 2020
Supplemental Digital Content is available in the text. Background: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting thousands of people ...
W. Alhazzani   +35 more
semanticscholar   +1 more source

Video versus Direct Laryngoscopy for Tracheal Intubation of Critically Ill Adults.

open access: yesNew England Journal of Medicine, 2023
BACKGROUND Whether video laryngoscopy as compared with direct laryngoscopy increases the likelihood of successful tracheal intubation on the first attempt among critically ill adults is uncertain. METHODS In a multicenter, randomized trial conducted at
M. Prekker   +43 more
semanticscholar   +1 more source

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.

open access: yesJournal of the American Medical Association (JAMA), 2020
Importance Coronavirus disease 2019 (COVID-19) is a pandemic with no specific therapeutic agents and substantial mortality. It is critical to find new treatments.
Chenguang Shen   +26 more
semanticscholar   +1 more source

Covid-19 in Critically Ill Patients in the Seattle Region — Case Series

open access: yesNew England Journal of Medicine, 2020
Background Community transmission of coronavirus 2019 (Covid-19) was detected in the state of Washington in February 2020. Methods We identified patients from nine Seattle-area hospitals who were admitted to the intensive care unit (ICU) with confirmed ...
P. Bhatraju   +17 more
semanticscholar   +1 more source

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.

open access: yesJournal of the American Medical Association (JAMA), 2020
Importance Effective therapies for patients with coronavirus disease 2019 (COVID-19) are needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced mortality in hospitalized patients with COVID-19 who required respiratory ...
J. Sterne   +37 more
semanticscholar   +1 more source

Acute kidney injury in the critically ill: an updated review on pathophysiology and management

open access: yesIntensive Care Medicine, 2021
Acute kidney injury (AKI) is now recognized as a heterogeneous syndrome that not only affects acute morbidity and mortality, but also a patient’s long-term prognosis.
P. Pickkers   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy